presented at the: 3rd stakeholders meeting & high level ... · 3rd stakeholders meeting &...

Presented at the:3rd Stakeholders Meeting & High Level Forum

11-13 October 2010Nairobi, Kenya

iiANDI Task Force Report - Nairobi - Kenya 11–13 October, 2010

Foreword

This is the second and final report of the Task Force to ANDI stakeholders. The first report (presented in 2009 at the 2nd Stakeholders Meeting in Cape Town), focused on the development of the Strategic and Business Plan for ANDI, which all stakeholders present overwhelmingly endorsed.

The current report focuses on the deliberations of the Task Force since Cape Town, which has resulted in the following achievements:• The agreement that the United Nations Economic Commission for Africa (UNECA) hosts ANDI

secretariat in Africa and the signing of a formal MOU between WHO and UNECA regarding this hosting.

• The agreement on ANDI governance board.• The call for Centres of Excellence that has resulted in numerous applications from African

institutions.• The initiation of the development of the ANDI Knowledge Management and R&D databases.

This progress will be presented to the 3rd ANDI Stakeholders meeting in Nairobi (October 2010), including the launching of the ANDI call for projects which the Task Force have been discussing since Cape Town.

It is clear that ANDI is an initiative that numerous Africans are excited about, and it is with this excitement that we, the Task Force have worked tirelessly over the past 2 years. We have concluded our work and are now pleased to hand over the oversight of ANDI to the board in Nairobi.

It has been a great pleasure and honour working with the various stakeholders.

Special thanks to the leadership of the WHO through the Special Programme for Research and Training in Tropical Diseases (TDR) for supporting our deliberations financially and technically.

The ANDI Task Force

iii ANDI Task Force Report - Nairobi - Kenya 11–13 October, 2010

Task Force Composition

1. ATADJA, Peter Dr, 9 Reeve Street, Acton, MA 01720, USA Tel: +1 617 8713447 [email protected]

2. BOTROS Sanaa Dr, Theodor Bilharz Research Institute, El-Nile Street,

Warrak El-hadar, Imbaba, P. O. Box 30, Giza 12411, Egypt, Tel: +202 35720355; +202 357249901

[email protected]

3. GUANTAI, Anastasia N. Prof, University of Nairobi, Department of Pharmacology and Pharmacognosy, College of Health Sciences, P.O. Box 19676, Nairobi 00202 Kenya

Tel: +254 020 2717865; Fax: +254 020 2717865

[email protected]

4. ILUNGA, Tshinko Dr, African Development Bank, African Development Fund, Human Development Department, B. P. 323, 1002 Tunis Belvedere, Tunisia Tel: +216 71 102117

Fax: +216 71 103784 [email protected]

5. INYANG, Uford Dr, formerly of National Institute for Pharmaceutical Research and Development, Idu Industrial Area, P. M. B. 21 Garki, Abuja, Nigeria

Tel: 234 9 780 3329 Mobile: 234 803 665 1043

[email protected]

6. KONDE Victor Dr, United Nations Economic

Commission for Africa (UNECA), [email protected] (cc. [email protected])

7. MBEWU, Anthony Dr, Global Forum for Health Research, 1-5 route des Morillons, P. O. Box 2100, CH-1211 Geneva 2 Tel: +41 22 791 6030 Mobile: +41 79 326 6951 Fax: +41 22 791 4394 anthony.

[email protected]

8. MBOYA OKEYO Tom Dr, Permanent Mission of Kenya, 1-3 Avenue dela Paix, 1202 Geneva, CH Tel. +41 22 906 4050

[email protected]

9. McCARTHY, Kevin Dr, Health Research Strategy and Policy Aspects, European Commission, Rue du Champ de Mars, Marsveldstraat 21, 1050 Brussels, Belgium Tel: +44 1382 386 240

[email protected] OR JAHN, Albrecht, Dr, Health Research

Strategy and Policy Aspects, European Commission, Rue du Champ de Mars, Marsveldstraat 21, 1050 Brussels, Belgium Tel: +44 1382 386

240 [email protected]

10. NWAKA, Solomon, Dr, Special Programme for Research and Training in Tropical Diseases, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland,

Tel: +41227913737, [email protected]

11. OCHEM, Alexander, Dr, Biotechnology Development Transfer, International Centre for Genetic Engineering and Biotechnology, University of Cape Town Campus, Cape

Town, South Africa, Tel. +27216507691, Email:

[email protected] (from 1 Jan 2009 - 30 Apr 2010)

12. OPOKU-MENSAH, Aida, Ms, United Nations

Economic Commission for Africa, Addis Ababa,

Ethiopia, [email protected]

13. RIDLEY, Robert G, Dr, Special Programme for Research and Training in Tropical Diseases, World Health Organization, 20 Avenue Appia,1211 Geneva 27, Switzerland, Tel: +41227913802,

Email: [email protected]

ivANDI Task Force Report - Nairobi - Kenya 11–13 October, 2010

Table of Contents

Foreword .........................................................................................................................................ii

Task Force Composition ............................................................................................................... iii

A. 5th Meeting of the African Network for Drugs and Diagnostics Innovation (ANDI) Task Force .................................................................................................................................1

I. Meeting agenda (please see Annex A1) ....................................................................................2

II. Discussion highlights:..............................................................................................................2

III. Action points ..........................................................................................................................5

B. 6th Meeting of the African Network for Drugs and Diagnostics Innovation (ANDI) Task Force .................................................................................................................................7

I. List of participants (see Annex B1) .........................................................................................7

II. Meeting agenda (see Annex B2) ..............................................................................................7

III. Strategic discussions and key decisions reached ........................................................................7

IV. Action points ..........................................................................................................................9

Annex B1: List of participants ........................................................................................................9

Annex B2: Meeting Agenda ..........................................................................................................10

Annex B3: Criteria for selection of ANDI Board and STAC. ........................................................12

C. 7th Meeting of the African Network for Drugs and Diagnostics Innovation (ANDI) Task Force ...............................................................................................................................14

I. List of participants (see Annex C1) .......................................................................................14

II. Meeting agenda (see Annex C2) ............................................................................................14

III. Strategic discussions, key decisions/recommendations. ..........................................................14

IV. Action points ........................................................................................................................16

Annex C1: List of participants .....................................................................................................16

Annex C2: Meeting Agenda ..........................................................................................................17

D. 8th Meeting of the African Network for Drugs and Diagnostics Innovation (ANDI) Task Force ...............................................................................................................................20

I. List of participants (see Annex D1) ......................................................................................20

II. Meeting agenda (see Annex D2) ............................................................................................20

III. Strategic discussions, key decisions/recommendations. ..........................................................20

IV. Action points ........................................................................................................................22

Annex D1: List of participants .....................................................................................................23

Annex D2: Meeting Agenda ..........................................................................................................24

Annex D3: Proposed board and STAC members ...........................................................................25

1 ANDI Task Force Report - Nairobi - Kenya 11–13 October, 2010

A. 5th Meeting of the African Network for Drugs and Diagnostics Innovation (ANDI) Task Force

25-26 January 2010Venue: Sheraton Sharm Hotel, Sharm-el-Sheikh, Egypt

Executive SummaryThe objective of the meeting was to review the progress in implementing the Strategic and Business Plan approved at the 2nd ANDI stakeholders meeting at Cape Town. ANDI Governance (Board, STAC and AIF) and criteria for selecting a host country for the ANDI secretariat and sub-regional hubs were discussed. Draft strategy documents for IP, value proposition for ANDI and advocacy were reviewed and next steps defined. The Task Force (TF) was pleased with the funding support from the EU and discussed mechanisms for raising the profile of ANDI and fundraising. Planning for the 3rd stakeholders meeting and objectives was also discussed.

List of participants

Task Force • Tom Mboya Okeyo (Chair), Permanent Mission of Kenya, Geneva• Alex Ochem (Secretary), International Centre for Genetic Engineering and

Biotechnology, South Africa• Sanaa Botros, Theodor Bilharz Research Institute, Egypt• Uford Inyang, National Institute for Pharmaceutical Research & Development,

Nigeria• Anastasia Guantai, University of Nairobi, Kenya• Anthony Mbewu, Global Forum for Health Research, Switzerland• Peter Atadja, Novartis, USA; representing African scientists in the Diaspora• Robert Ridley, TDR • Solomon Nwaka, TDR

WHO Secretariat

• Robert Ridley, TDR • Solomon Nwaka, TDR• Foluke Fakorede, TDR• Issa Sanou, RPC/AFRO• Mohammad Afzal, RPC/EMRO

Others • Albrecht Jahn, European Commission, Belgium• Fatma Hamza, Vacsera, Egypt• Yousry El-Shaih, EIPICO, Egypt• Mohamed Rabie, Vacsera, Egypt• Nayel Sobhy, Delta Pharma, Egypt• Glaudina Loots, Dept Science & Technology, South Africa• TF Okujagu, Ministry of Science & Technology, Nigeria• Jean Sakandé, Ministry of Health, Burkina Faso

2ANDI Task Force Report - Nairobi - Kenya 11–13 October, 2010

Unable to participate:

Task Force • Tshinko Ilunga (Vice-Chair), African Development Bank, Tunisia• Kevin McCarthy, European Commission, Belgium

I. Meeting agenda (please see Annex A1)

II. Discussion highlights:

• Update on ANDI and progress since last meeting in Cape Town (October 2009):

An overview of activities following the last meeting was provided. The Task Force (TF) welcomed the progress to date and thanked the EU for the funding support (€5M) provided for the preparatory work in establishing ANDI and other networks. This would also enable the recruitment of urgently required personnel to support implementation efforts. ANDI had a visible presence at a number of relevant meetings (MIM (Nairobi, November 2009), Global Forum for Health Research (Havana, November 2009), ASTMH (Washington DC, November 2009)) and was also mentioned during deliberations on the GSPOA at the WHO Executive Board meeting in January 2010. Ongoing discussions and a visit to the African Development Bank (AfDB) on the creation of the African Innovation Fund (AIF) and hosting arrangements were very fruitful but more work is required.

• Strategic discussions on ANDI implementation:

1. Governance

The board will provide overall strategic and financial oversight of ANDI activities. It is expected that AfDB will host the AIF and provide the legal umbrella for the establishment of ANDIs operation in Africa. It is anticipated that the ANDI board will have a strong intergovernmental representation. In addition, it is expected that the following constituencies will be represented in the board - researchers, private sector, Africa-based non-governmental organizations, regional economic groupings of Africa, health-related international organizations, OECD and AU. The structure of the board is such that there will be a strong African ownership - with African regions including the AU having over 70% of the memberships. It was suggested that board meetings could coincide with annual stakeholders meeting (e.g. the first meeting of the ANDI board is proposed to immediately follow the 3rd stakeholders meeting later this year). A small group* was identified to review and finalize the profile and criteria for selection of the Board members as well as define criteria (including the scope of expertise required) for selecting Scientific and Technical Advisory Committee members.

It was recognized that the criteria for specific groups represented in the board may differ e.g. representatives of researchers, diaspora groups, private sector etc. The TF agreed that it is very urgent to finalize the legal hosting arrangement with the AfDB, and to hold a follow up meeting with the senior management of the Bank before the next TF meeting.

Scientific and Technical Advisory Committee (STAC) will provide external and independent review for ANDI research and technical projects including the selection of projects, review of ongoing project and the entire ANDI portfolio. The composition will be proposed by ANDI secretariat based on established criteria and formally approved by the board, although if the need arises, the TF may be required to establish an interim committee pending this approval.

*Ridley, Okujagu, Mbewu, Guantai and Sanou


2. Hosting of ANDI and call for applications

The call for applications for hosting the ANDI secretariat and subregional hubs should be prepared and announced in March (to coincide with AMCOST). This process should be supported with proactive contact with countries that have already informally expressed interest in hosting the ANDI secretariat or subregional hubs. Final selection will be made by the ANDI board. Important consideration must be given to the minimum requirements and level of country commitment/support needed to host the secretariat; hence these criteria will be further developed by the small group. The importance of making the call available in French, Portuguese and Arabic in addition to English was also stressed.

A draft call for letters of intent (LOI) for ANDI network projects was reviewed. The discussion centered on the scope of the call and whether there was a need for disease specificity or preference. It was felt that the disease scope should be left broad at this stage. A small group+ was tasked with strengthening the call by taking into consideration, this feedback. The TF recommended that the call be published only when there is additional financial commitment to support at least 2 network projects.

• ANDI IP strategy:

The draft document outlined the steps for establishing an IP policy that is consistent with ANDI’s mission. Two areas of focus are: a) providing IP support around ANDI projects and, b) building capacity in IP management to ensuring long term sustainability. It is expected that technical guidance and support from WIPO and WTO on the implementation of the IP strategy will continue, while existing materials from national and sub-regional groups e.g. national IP handbooks from Nigeria, Kenya and South Africa, should inform this policy. The TF recommended that the document be updated based on input and shared. Additional input from IP experts should be solicited for example through WIPO, ARIPO and OAPI. A detailed mapping of the African IP landscape may be needed to establish a solid baseline.

• ANDI advocacy strategy:

A draft document prepared by TDR communications manager was reviewed and discussed. Although the content was very much from a TDR perspective, it serves as a good basis for developing an ANDI advocacy strategy document. Proposed modifications (to be provided by TF) will be fed back to the communications team.

The TF expressed some concern over the lack of financial commitment from African governments to date. It was felt that the broad advertisement of the EU support should be used to sensitize other donors while stressing the need for financial commitment from Africa and African ownership. Additional fundraising strategies would most likely be addressed in the finance strategy document being developed by the TF. The TF was urged to initiate and support fundraising activities.

• ANDI website and database:

The TF requested the urgent development of an independent ANDI website to support ongoing efforts in raising awareness, engaging stakeholders and fundraising. This site should also facilitate collaboration and serve as a broader knowledge management platform for relevant research and information in Africa (not just for ANDI supported activities). A brochure and PowerPoint slides would also be useful tools in advocacy for ANDI.

+Atadja, Botros, Nwaka, Jahn, Guantai, Sakandé and Hamza


• Value proposition for ANDI:

A summary slide of the value proposition for various stakeholders (public and private) and their potential benefits from investing in ANDI was presented. This was received and seen as a powerful tool to support advocacy. SN and TM integrated this and other available information into a word document that can be shared with TF for additional input. The TF also recommended that most of the information in the value proposition be used to develop a strong advocacy document and brochure for ANDI. It was felt that the services of an external consultant to develop the value proposition further, were no longer required. However, external support may be required to develop a strong advocacy document and brochure.

• ANDI finance strategy:

Discussion was postponed until the draft report had been circulated. The TF requested that it be made available within 2 weeks.

• 3rd Stakeholders meeting (11-13th October, Nairobi):

The meeting objectives, budget and proposed format were discussed and agreed upon. The Minister of Public Health and Sanitation will be the official host of the meeting, which will take place at the UN offices. It is anticipated that a high level ministerial consultation will also be an integral part of the agenda, and that the ANDI board will also convene a meeting during this event. A local organizing committee has been constituted and it is expected that they will meet in February or March. Additional names were suggested, and the final list of members will be circulated to the TF.

• AOB.

- In order to strengthen the participation of Francophone researchers a small meeting will be convened as soon as possible, with the assistance of Sakandé and Sanou.

- A meeting of African pharmaceutical manufacturers will also be convened. To ensure broad participation, relevant national and subregional associations could be obtained from IFPMA. Other invites would include WHO (prequalification unit), UNITAID and UNIDO. The upcoming NEPAD/COHRED meeting on local manufacturing in Pretoria (February 2010) is viewed as a good forum to publicize the meeting. Egyptian, Kenyan and South African observers will take the lead in organizing this event.

- The possibility of exploring the involvement of pharmaceutical company foundations was also discussed.

- Linkages with other key programs and initiatives (e.g. NEPAD, COHRED) supporting R&D in Africa, were discussed.

Timeline for 2010 Task Force meetings.

- The Task Force discussed and agreed on the schedule of future meetings for 2010 as follows:

Date Activity

April/May AU, Addis Ababa, Ethiopia.

August/September UN, Nairobi, Kenya

11 - 13 Oct 2010 3rd ANDI stakeholders Meeting, UN Offices, Nairobi, Kenya


III. Action points

• CriteriaforselectingboardandSTACmemberstobeshared(TDR)• Callforapplicationsforidentifyinghostcountrytobedrafted(TDR)• RevisionofdraftLOIforANDIprojects(selectedTFmembers)• Draftfinancestrategytobecirculated(IlungaandInyang)• DraftTORforselectingIPstrategyconsultantandsharewithTF(TDR)• Consolidatedvaluepropositiondocumenttofinalizedandshared(NwakaandMbewu)• RevisionstodraftadvocacystrategydocumentfollowingTFfeedback(TDRCommunications)• ANDIadvocacybrochureandslidestobedeveloped(TDR)• ExploredevelopmentofANDIwebsiteaheadofOctobermeeting(TDR)• Francophonemeetingconcepttobedrafted(SanouandSakande/TDR)• Africanpharmaceuticalmanufacturersmeetingconcepttobedrafted(selectTF/TDR)• 3rd stakeholders meeting brochure to be prepared and online registration launched (TDR)• LOCnamestobefinalizedandmeetingscheduledbeforeMarch(Guantai)

Annex A1. Meeting Draft AgendaMonday 25 January 2010

09:00 - 09:20 Opening remarks & introduction

Welcome remarks

Dr Tom MBOYA OKEYO Chair, ANDI task ForceDr. Rob RIDLEY, Director TDREgyptian officials/Dr Sanaa BOTROS

09:20

09:40

-

-

09:40

10:40

Update since last meeting incl- suggested updates to SBP and wider dissemination

- AfDBStrategic discussions on implementation of ANDI SBP

Governance•ProcessforselectionofANDIBoardmembers•ProcessforselectionofScientific&Technical•Advisorycommittee•AfricanInnovationFund

Hosting of ANDI in Africa and call for applications•ProcessforidentificationofAfricanhostcountry for ANDI and hubs (under the legal framework of the AfDB)•ReviewcallforANDIprojects

Dr Solomon NWAKA Leader, Drug Discovery and Innovation Research, WHO/TDR

10:40 - 11:00 Coffee

11:0012:30

--

12:3013:00

Strategic discussions on implementation of ANDI SBP cont›dDiscussion on ANDI finance strategy (prepared by T. Ilunga/U. Inyang)


13:00 - 14:00 Lunch

14:00

15:00

-

-

15:00

15:40

Discussion on ANDI IP strategy (prepared by S. Nwaka/S. Botros)

Discussion on the ANDI value proposition proposal and terms of reference (prepared by A.Mbewu/S. Nwaka)

15:40 - 16:00 Coffee

16:00 - 17:00 Discussion on ANDI Advocacy (prepared by R. Ridley/P. Atadja) •Briefingdocument •Advocacystrategy•Diasporaengagement

17:00 - 18.00 Planning for 3rd ANDI meeting (Nairobi)Meeting objectivesLocal organizing committeeBudgetTimelines for planning

Tuesday 26 January 2010

09:00 - 10:00 Potential linkages with other efforts Glaudina LOOTS

10:00

10:45

11:30

-

-

-

10:45

11:30

12:00

Meeting summary

Next steps for implementation Incl. Next TF meeting

AOB

Secretary

12:00 Close


B. 6th Meeting of the African Network for Drugs and Diagnostics Innovation (ANDI) Task Force

3-4 May 2010Venue: UNECA, Addis Ababa, Ethiopia

Executive SummaryThe 6th meeting of the ANDI Task Force was held at UNECA on 3-4 May 2010. Representatives from the various organizations present, including UNECA, AfDB, AU (AMCOST), WHO as well as African research institutions and ministries, reiterated their commitment to ANDI. The Director ICT, Science and technology UNECA welcomed the ANDI initiative and the significant synergy it has with its own initiatives. In this context, the proposed African Innovation Fund of ANDI being developed with the AfDB is relevant to UNECA’s African Science, Technology and Innovation Endowment Fund - ASTIEF. UNECA expressed strong desire to work with ANDI in implementing the fund and other activities such as its Network of African Centres of Technology Development and Transfer which will be launched in June, and promotion of public private partnerships in support of economic development. UNECA also expressed the desire to potentially provide hosting support for ANDI. The Task Force thanked UNECA for hosting the meeting. It welcomed the progress made to-date in preparation for the transition of ANDI to Africa including: presence at major meetings such as the AMCOST and the NIH G8 consultation; the initiation of the development of the ANDI database; and planning the 3rd stakeholders meeting in October Nairobi Kenya. Key decisions were made by the task force with respect to the legal hosting, governance (Board and Scientific and Technical Advisory Committee) and calls for proposals. Specific recommendations derived from this meeting are presented below.

I. List of participants (see Annex B1)

II. Meeting agenda (see Annex B2)

III. Strategic discussions and key decisions reached

• The following key decisions were reached regarding Legal hosting and Governance of ANDI:

1. The Task Force asks WHO/TDR to request the RD AFRO, in consultation with RD EMRO, to facilitate discussions with African organisations (including but not limited to UNECA, AfDB, AU and its specialized technical committees (AMCOST and AU Ministers in charge of health)) with the aim of identifying an organisation that would be willing to host ANDI and its Secretariat.

2. The Task Force further requests that these discussions lead to the establishment of the ANDI board based upon the Strategic and Business Plan.

3. It is desirable that the identification of the host organisation is completed no later than the end of June 2010.

4. The Task Force commits itself to issuing the call for the hosting of ANDI hubs subject to finalization of the legal hosting arrangements.


5. The aforementioned tasks need to be completed prior to the 3rd Stakeholders meeting in Nairobi this October (10th-15th 2010).

• The following key decisions were reached during technical deliberations:

6. The Task Force (TF) drafted criteria for the selection of board and STAC members (see Annex B3). This document will aid the consultations to be convened by RD AFRO. If needed, TF members are willing to provide technical support for any meeting held to support the consultations.

7. The TF reviewed the draft call for physical hosting of the ANDI secretariat and hubs in Africa, and requested that the call be revised along the lines agreed by TF and shared once again for approval. The goal is to issue the call in the first week of July, once the issue of legal hosting for ANDI is addressed. In revising the call it is important to clearly define legal hosting versus physical hosting of ANDI to avoid confusion.

a. Legal Hosting refers to the conferment of intergovernmental status to ANDI by an existing intergovernmental or international institution based in Africa. This means that ANDI will derive its legal status from that organization and ANDIs administrative and fiduciary functions will be linked to that of the host organization. However, ANDI will have its own governance and be accountable to it own board.

b. Physical Hosting refer to the physical location of the ANDI secretariat and the hubs as well as staff. The physical location of ANDI should be selected based on call for proposal requesting African countries to bid for the hosting based on a set of criteria. However, should an organization providing legal hosting for ANDI offer enough space for the ANDI secretariat in the interim and meets the criteria for physical hosting of the secretariat, then only the call for hubs will be announced.

8. Call for ANDI projects

The TF reviewed the draft call for letters of intent (LOI) for projects and the proposal template, and offered suggestion for finalization of the call. The TF recommended that the call be issued in 2 phases as follows - a call for centers of excellence, followed by a call for specific network projects:

i. Call for centers of excellence - to identify existing centres of excellence across Africa in both public and private sectors, with capacities and expertise in the various areas of product R&D. This will help to map existing capacities, capabilities and infrastructure. Available centres of excellence could become technical affiliates of ANDI and be used to support the specific network projects once identified. The centres of excellence could be publicized through the ANDI database and website. The TF urged for this call to be launched immediately and findings presented during the October Stakeholders meeting. The TF agreed that the call will give ANDI a boost and could support fundraising.

ii. Call for specific network projects (including investigator initiated projects) - to identify viable projects with potential to develop products for the treatment or prevention of diseases that disproportionately affect the African continent. This will be launched during the October Stakeholders meeting. The TF agreed that the scope of the call should be as broad as possible to identify available projects in the various parts of the value chain. Selected proposals could leverage relevant centers of excellence for project implementation.

9. ANDI Database

The TF requested that the short listing of applicants be finalized and submitted to TF speedily to ensure final selection meets the timeline for presentation at the October meeting.


IV. Action points

Task Responsible person(s)

Deadline

Initiate meeting with RD AFRO and African organizations TDR 21/05/10

Finalize draft call for physical host of ANDI secretariat & hubs TDR 21/05/10

Finalize board and STAC selection criteria & share with TF TDR 21/05/10

Finalize draft call for centers of excellence & R&D projects TDR 21/05/10

Launch call for centers of excellence TDR 30/05/10

ANDI advocacy brochure to be finalized (with FAQs) TDR 14/05/10

Updated IP strategy to be shared SN/SB 14/05/10

Updated value proposition to be shared SN/AB 14/05/10

Pharmaceutical manufacturers meeting concept drafted SB/GL/AG/UI 14/05/10

Stakeholders meeting brochure to be prepared TDR 31/05/10

Requested documents to be shared with LOC FF 07/05/10

LOC and TDR to proceed with planning for the meeting as agreed LOC/TDR

Timeline agreed for Task Force meetings 2010.

Date Activity

June TF Teleconference to determine status of legal hosting and establishment of Board

1st and 2nd July Face-to-face meeting to finalize hosting arrangement, and establishment of the Board. Venue tbd (Geneva?)

August/September UN, Nairobi, Kenya - finalize plan for 3rd stakeholders meeting


Annex B1: List of participants

Task Force Tom Mboya Okeyo (Chair), Permanent Mission of Kenya, Geneva*

Tshinko Ilunga (Vice-Chair), African Development Bank, TunisiaAlex Ochem (Secretary), International Centre for Genetic Engineering and Biotechnology, South AfricaSanaa Botros, Theodor Bilharz Research Institute, EgyptUford Inyang, National Institute for Pharmaceutical Research & Development, NigeriaAnastasia Guantai, University of Nairobi, KenyaRobert Ridley, TDR* Solomon Nwaka, TDR

WHO Secretariat

Robert Ridley, TDR* Solomon Nwaka, TDRFoluke Fakorede, TDRIssa Matta, WHO*


Others Maged Al-Sherbhiny, Ministry of Scientific Research, Cairo, Egypt*

Abdel- Hamid Zoheiry, Ministry of Scientific Research, Cairo, Egypt*

Glaudina Loots, Dept Science & Technology, South AfricaJohn Amuasi, Komfo Anokye Teaching Hospital, Ghana+

Victor Konde, UNECA, EthiopiaThierry Amoussougbo, UNECA, EthiopiaAhmed Hamdy, AU, Ethiopia*


Task Force Anthony Mbewu, Global Forum for Health Research, SwitzerlandPeter Atadja, Novartis, USA; representing African scientists in the DiasporaKevin McCarthy, European Commission, BelgiumAlbrecht Jahn, European Commission, Belgium

*participation on day 1; +participation on day 2

Annex B2: Meeting Agenda

Monday 3 May 2010

09:00 - 09:15 OPENING REMARKS Introduction/Meeting Objectives

Dr Tom MBOYA OKEYO

09:15 - 09:45 Welcome Dr Aida Opoku-Mensah Director, ISTD, UNECADr Fatoumata NAFO-TRAORE WR EthiopiaDr Olawale MAIYEGUN, Director, Social Affairs Department AUCDr Robert G. RIDLEY Director, TDRDr Tshinko ILUNGA Acting Director, Human Development Department, ADB

09:45 - 10:30 Update since last meeting Dr Solomon NWAKA Leader, Drug Discovery and Innovation Research, WHO/TDR

10:30 - 10:50 Coffee


10:50 - 11:45 Strategic discussions on implementation of ANDI SBP

Governance and institutional hosting of ANDI•IntergovernmentalVsNGO-currentstatusofdiscussion•AfricanInnovationFunds-currentstatusofdiscussion•ProcessforselectionofANDIBoard•ProcessforselectionofScientific&TechnicalAdvisorycommittee•TransitionfromANDITaskForcetointerimBoard.

Call for physical hosting of ANDI hubs in Africa and call for applications•ReviewrevisedcallforANDIprojects•ANDIdatabasecallupdate•ReviewofdraftcallforhostcountryforANDIandsubregionalhubs

12:45 - 14:00 Lunch

14:00 - 15:40 Strategic discussions continued

15:40 - 16:00 Coffee

16:00 - 16:45 ANDI finance strategy update Dr Tshinko ILUNGA and Dr Uford INYANG

16:45 Discussion and summary of Day 1 Chair and Secretary

Tuesday 4 May 2010

09:00 - 09:45 ANDI IP strategy update Dr Solomon NWAKA and Dr Sanaa BOTROS

09:45 - 10:40 ANDI value proposition proposal update Dr Anthony MBEWU and Dr Solomon NWAKA

10:40 - 11:00 Coffee

11:00 - 12:30 ANDI Advocacy update •Briefingdocument •Francophoneconsultation•Pharmaceuticalmanufacturersmeeting•Traditionalmedicinesconsultation •Diasporaengagement

12:30 - 14:00 Lunch

14:00 - 14:45 Update on planning for 3rd ANDI meeting (Nairobi)Registration Meeting format and documentationReport from local organizing committeeBudgetTimelines for planning

14:45 - 15:00 Meeting Summary Secretary

15:00 - 15:30 Next steps for implementation Next Task Force meeting

15:30 AOB and Close of Meeting Dr Tom MBOYA OKEYO


Annex B3: Criteria for selection of ANDI Board and STAC.

In compliance with the provisions of the Business Plan the following criteria were developed for the selection of members of the Board as well as the STAC of ANDI. It is expected that members of these executive bodies are endowed with a mix of these qualities.

Board• CommitmenttoANDImissionandobjectives*• Politicaland/ortechnicalweight*• Experienceinestablishingsuccessfulsystems/structures/organizationswithsignificantimpact• Experiencewithinstitutionalmanagement/HealthSystemsmanagement/Researchsystems• Experienceindevelopinghealthpolicies• Boardmembershipexperience*• Wellconnectednationally,intherespectiveregionandbeyond*-Evidenceofcollaboratingand

networking in the region)• Willingnesstodedicateatleast5%(approx12daysperyear)oftimetoboardactivities*• Provideamultisectoralperspective• Leadershipskills(basedupontrackrecord)*• Communicationskills*• Willingnesstoengageinfundraisingandadvocacyactivities*• Proventrackrecordinresourcemobilization• HealthEconomicsandpolicyexpertise• Demonstratedentrepreneurshipskills• Understandingofpublicandprivatesectors/partnerships• Understandingofintellectualpropertyissues• UnderstandingofAfricanhealthneedsanddevelopmentissues*• Eminentandrespectedpeopleofintegrity*• Experienceinfinancialmanagementandcontrol• Understandingofscience,technology,innovationandeducation• R&Dandinnovationmanagementandexperience• Researchandinnovationpolicyexpertise• WillingnesstoserveintheExecutiveandFinancialsubcommittees*• Pharmaceuticalproductdiscovery/development/delivery/accessknowledge• Experienceincapacitybuilding• Nosalarypaidbuttravelandsubsistenceallowanceduringmeetingsaccordingtotherulesofthe

legal host

*Criteria to be met by all board members

STACComposition to cover all aspects of the value chain • Discovery–3experts • Preclinical–2(Toxandethics) • Clinicalresearch–1 • Regulatoryaspects–1 • Fieldevaluationofdiagnostics–1 • Manufacturing–1 • IP/Techtransfer–1 • Access/implementationresearch/healthsystemsresearch–1 • Policy-1


Criteria for selection • 70%-African:Africa-based/Diaspora • 30%-International • Wellbalancedwrtyoung/older&male/female • Electedinindividualcapacity • Internationalrespectedscientists • Proventrackrecordinfieldsofexpertise • Broaddiseaseknowledge • Electedfor2years,renewableforanother2years • Atleast7memberstobereplacedafter2years • Needtoensurecontinuity


C. 7th Meeting of the African Network for Drugs and Diagnostics Innovation (ANDI) Task Force

1-2 July 2010Venue: WHO/TDR, Geneva, Switzerland

Executive SummaryMembers of the task force, including representatives from UNECA, AfDB, WHO, African research institutions and ministries reviewed progress in implementing the ANDI strategy. A key decision was reached on the legal hosting arrangements for ANDI by UNECA. It was also agreed that AfDB host the ANDI fund and WHO to provide programmatic technical support. It was agreed that a formal MOU between the 3 organizations be initiated with a view to finalizing an agreement by August 2010. This will enable the 3 parties to become formal co-sponsors of ANDI.

Technical discussions focused on the draft calls for proposals for ANDI hubs and network projects, strategic documents (e.g. IP, value proposition for ANDI) and advocacy plans. Next steps were clearly defined and agreed upon. The TF endorsed the selection of the vendor for developing the ANDI Knowledge Management and R&D database and an update on planning for the 3rd Stakeholders Meeting and objectives was presented.

I. List of participants (see Annex C1)

II. Meeting agenda (see Annex C2)

III. Strategic discussions, key decisions/recommendations.

• Decisions on Legal hosting and Governance of ANDI:

1. Legal hosting - A firm decision for partnership between WHO, UNECA and AfDB in moving ANDI forward, was reached and accepted by the TF.

Legalstatus–UNECA,

HostingofAfricanInnovationFund–AfDB,

Technicalprogrammaticsupport–WHO.

It is hoped that the formal agreement will be finalized by the next TF meeting in August or Sept., 2010

2. Governance - It was agreed that a small ANDI Board be implemented in time for the launch at the 3rd Stakeholders meeting in Nairobi. The Board will initially be made of 10 - 12 members, with 5 core members coming from the African regional economic groupings. The Board composition should be such that 70% of members should come from Africa. TF members were requested to urgently provide recommendations for board membership bearing in mind the set criteria that was drafted during the last TF meeting in Addis Ababa (May 2010). It is expected that membership of the board may be expanded at a later date if necessary. Furthermore, the process for the appointment of board members is to be agreed with UNECA. The TF also suggested that if possible, the board could meet jointly with the TF before the Nairobi meeting.


• Technical deliberations and decisions:

3. Calls for hubs - The revised call was reviewed and input provided by the TF. It was agreed that input from TF be incorporated and finalized in consultation with UNECA. It was agreed that the call be released by the end of July. A final version should be shared with the TF once available

4. Callsfornetworkprojects–TherevisedcallwasreviewedandadditionalinputprovidedbyTF.A revised version is to be shared with the TF as soon as possible for final review. The scheduled timeline for launching the call (October 2010) stands.

5. ThecallforCentresofExcellence–Thiscallwaslaunchedon10June2010andhasalreadygenerated significant interest. A draft evaluation form was proposed and reviewed, and following inputs from members will be revised to yield the scoring system for applications and be finalized by the end of July.

6. Strategy and advocacy documents - The current versions of the Value proposition and IP strategy documents will be shared with the TF, who are requested to provide input by end of July. It was suggested that separate value proposition documents be prepared to reflect the expectations of different ANDI stakeholder groups at a later date.

7. Pharmaceuticalmanufacturersmeeting–Themeetingconcept,objectivesandoutcomesneedtobe developed, however following further discussion, the TF did not view this as a current priority.

8. MeetingofFrenchspeakingAfricancountries–Arevisedmeetingconceptnoteswouldbefinalized and shared. It was recommended that this meeting take place just before the next TF meeting in August+. The ANDI Strategic Business Plan requires urgent translation into French as this will be the key document for this meeting.

9. ANDIDatabase–AdemooftheproposedsolutionprovidedbyLogica/DDTechwaspresentedand the TF endorsed selection of Logica/DDTech in developing the ANDI Knowledge Management and R&D platform. They urged that the project be implemented rapidly to ensure that the timeline for launching a demo during the 3rd stakeholders meeting is achieved.

10. Stakeholdersmeeting–Appreciationwasexpressedfortheprogressreportfromthelocalorganizing committee after its review. The proposed meeting agenda is to be revised following input from TF and shared with the members as soon as possible. Formal invitations for VIPs and meeting delegates should be finalized to aid LOC on the invitation process. The precise roles of some prospective ministers/VIPs in attendance should be clearly defined and communicated to these upon confirmation of participation.

+Post meeting update: Note that the tentative date of this meeting was later revised to the 2nd week of September.

• AOB

Diaspora strategy to be developed, possibly with assistance from TDR’s Empowerment unit.Development of concept note for a traditional medicine consultation meeting ongoing.The LOC announced their hope to have the President of Kenya and the Prime Minister to formally open and close the 3rd stakeholders meeting respectively.


IV. Action points

Task Responsible person(s) Deadline

WHO, UNECA and AfDB to finalize 3-way partnership agreement

TDR/UNECA/AfDB 01/09/10

TF to provide names of potential board members TF 31/07/10

Process for appointment of board members to be finalized TDR/UNECA 01/10/10

Finalize call for ANDI hubs and launch TDR/UNECA 31/07/10

Finalize call for R&D projects and share with TF TDR 12/07/10

Revise evaluation form for call for centers of excellence TDR/GL 31/07/10

Updated IP strategy to be shared and TF input provided SN/SB 31/07/10

Updated value proposition to be shared and TF input provided SN/AB 31/07/10


French-speaking Africa meeting notes revised and shared IS/JS/TDR 12/07/10

Translation of Strategic Business plan into French TDR/UNON/IS 15/08/10

LOC and TDR to proceed with planning for the meeting as agreed (particularly for fund-raising, invitations, and facilitating visa on arrival processes).

LOC/TDR


Date Activity

Proposed dates are:26-27th August

UN, Nairobi, Kenya - finalize plan for 3rd stakeholders meeting


Annex C1: List of participants

Task Force Tshinko Ilunga (Vice-Chair), African Development Bank, TunisiaAnthony Mbewu, Global Forum for Health Research, Switzerland*Peter Atadja, Novartis, USA; representing African scientists in the DiasporaSanaa Botros, Theodor Bilharz Research Institute, EgyptUford Inyang, National Institute for Pharmaceutical Research & Development, NigeriaAnastasia Guantai, University of Nairobi, KenyaAida Opoku-Mensah, UNECA, EthiopiaVictor Konde, UNECA, EthiopiaRobert Ridley, TDRSolomon Nwaka, TDR


WHO Secretariat

Robert Ridley, TDRSolomon Nwaka, TDRFoluke Fakorede, TDRAlex Ochem, TDRIssa Matta, WHOIssa Sanou, AFROMohammad Afzal, EMROPeter Mertens, WHO*

Others Glaudina Loots, Dept Science & Technology, South AfricaTF Okujagu, Ministry of Science & Technology, NigeriaJean Sakandé, Ministry of Health, Burkina FasoJohn Amuasi, Komfo Anokye Teaching Hospital, GhanaDaniel Motlhanka, Botswana College of Agriculture, Botswana


Task Force Tom Mboya Okeyo (Chair), Permanent Mission of Kenya, GenevaKevin McCarthy, European Commission, BelgiumAlbrecht Jahn, European Commission, Belgium

*participation on day 1

Annex C2: Meeting Agenda

Thursday 1 July 2010


Welcome remarks

Dr Tom MBOYA OKEYO Chair, ANDI task ForceDr. Rob RIDLEY, Director TDRDr Tshinko ILUNGA (Co-Chair ANDI TF), Acting Director, Human Development Department, ADBMs Aida OPOKU-MENSAH, Director S&T, UNECARepresentative of AU

09:45 - 10:30 Update since last meeting & meeting objectives


10:30 - 10:50 Coffee


10:50 - 11:45 Strategic discussions

Governance, legal hosting ANDI and hosting of ANDI FUND•UpdateondiscussionswithWHO/AFRO,UNECA,AfDB,AUandanymeeting between these organizations regarding legal hosting of ANDI•UpdateonBoardestablishment•OutstandingissueswithlegalhostingofANDIandnextstepstoresolvingthose in time for October meeting•UpdateonhostingofANDIfundatAfDBandUNECA

Call for physical hosting of ANDI hubs in Africa and call for applications•ReviewofdraftcallforhostcountryforANDIhubs•UpdateontheCallforCentresofExcellence•ReviewofrevisedcallforprojectstobelaunchedinOctober

12:45 - 14:00 Lunch


15:40 - 16:00 Coffee

16:00 - 16:45 Partnership and fund raising opportunities for ANDI

Dr Peter MERTENS, PUN/WHO

16:45 Discussion and summary of Day 1

18.00 Reception - TDR Cafeteria

Friday 2 July 2010

09:00 - 09:45 ANDI IP strategy updateANDI value proposition update

09:45 - 10:40 ANDI Advocacy and finance strategy update Status of other activities/consultations:Pharmaceutical manufacturers meetingFrancophone consultationTraditional medicines consultation Diaspora engagement

10:40 - 11:00 Coffee


11:0011:45

--

11:4512:30

ANDI database - demo from selected applicantUpdate on planning for 3rd ANDI meeting (Nairobi)Registration Meeting agendaMeeting format and documentationExpected meeting outcomes - launch Board/STAC, Centres of ExcellenceReport from local organizing committeeBudgetTimelines for planning

12:30 - 14:00 Lunch

14:00 - 15:15 Meeting Summary - Next steps for implementation

15:15 - 15:30 AOBs Next Task Force meeting Close of meeting


D. 8th Meeting of the African Network for Drugs and Diagnostics Innovation (ANDI) Task Force

26-27 August 2010Venue: UNON, Nairobi, Kenya

Executive SummaryMembers of the task force, including representatives from UNECA, AfDB, WHO, African research institutions and ministries reviewed progress in implementing the ANDI strategy.

The MoU between WHO and UNECA on the legal hosting of ANDI at UNECA will be finalized in September 2010 in time for the Nairobi meeting. There was general agreement for the proposed board and STAC membership and also for the recruitment of interim ANDI personnel. The proposed board members should be appointed through UNECA (once the MoU) is signed to enable implementation of the 1st Board meeting early in October (before the Nairobi meeting). The TF congratulated the LOC in their progress towards planning the 3rd Stakeholders Meeting and urged them to rapidly send out the remaining invitation letters. A number of advocacy and strategic issues were discussed and next steps were clearly defined and agreed upon.

I. List of participants (see Annex D1)

II. Meeting agenda (see Annex D2)

III. Strategic discussions, key decisions/recommendations.

• Legal hosting and Governance of ANDI:

1. Legal hosting - Progress has been made in negotiating the MoU between WHO and UNECA. It is expected that this agreement would be finalized in the coming weeks (ahead of the 3rd Stakeholders meeting). Inclusion of the AfDB in the MoU to host the ANDI fund will only be feasible pending the approval of its Board of Directors and Governors and after the the legal status of ANDI is clarified through the MoU between WHO and UNECA. AfDB continues to be interested in the work and will continue to support ANDI technically pending approval to join the MoU.

2. Governance - A list of proposed Board and STAC members was reviewed, revised and agreed (see Annex 3). Appointment letters should be sent to Board members by UNECA once the MoU is signed.

Board: Proposed membership comprises representatives from the 5 sub regions of Africa, in addition to WHO, UNECA, AfDB, Diaspora, internationally recognized Africans, health experts and the EU. Details on the nature, constitution and appointment of the board will be stipulated in the MoU. The board is scheduled to meet one day prior to the Stakeholders meeting.


STAC: Proposed membership comprises current Task Force members and other eminent scientists with expertise spanning the R&D value chain, in addition to other areas. STAC membership should be adjusted (and if necessary increased to include co-opted members) to ensure that the necessary expertise is available on the committee. The Task Force will be transitioned to an interim-STAC pending approval of the STAC by ANDI Board.

3. African Innovation Fund - There was some discussion on whether the proposed AIF should operate as an endowment fund from the outset as opposed to a collection fund. Although an endowment fund is important (particularly in view of the sustainability needs for ANDI) it is recognized that some donors are unable to contribute to endowment funds. There was general agreement that the fund should operate initially as collection and trust funds to allow the gradual development of the endowment. The ANDI Board will review the nature of the fund once it is in place. In the time being it will operate through UNECA (either through UNECA’s ASTIEF and/or a trust fund), and fundraising will commence immediately following the signing of the MoU.

• Technical deliberations and decisions:

4. Calls for hubs - The revised call was reviewed and input provided by the TF. It emerged from these discussions that a more targeted approach in the identification of the hubs would be more suitable than issuing a call. This will ensure proactive and focused negotiations with countries from the different regions that have strong interest in hosting the hubs. Consideration will also be in view of an analysis of the Centres of Excellence proposals and criteria given in the Strategic Business Plan. It may be appropriate to announce the expression of interest from countries at the 3rd ANDI stakeholders meeting in Nairobi. The TF recommended that this be further discussed between WHO and UNECA.

5. Callsfornetworkprojects–TherevisedcallwasreviewedandadditionalinputprovidedbyTF. A revised version is to be shared with the TF as soon as possible for final review. The call is scheduled to be launched at the Nairobi meeting in October 2010.

6. ThecallforCentresofExcellence–TheTFwereverypleasedwiththehighnumberofsubmissions (>110 applications from the 5 sub regions of Africa) and the overall interest expressed by the African research community. The process of review and selection is to be finalized.

7. Diaspora engagement - A draft strategy document is being developed. Once finalized, this will be shared with TF for review.

8. MeetingofFrenchspeakingAfricancountries–Thedateshavebeenrevisedto27-28September. Formal approval to hold the meeting has been obtained from the regional director of AFRO and the business plan translation will be completed by the end of August. Local coordination of the meeting will be by the WHO office in Burkina Faso. Approximately 30 participants will be expected.

9. Stakeholdersmeeting–ThelocalorganizingcommitteeandUNONprovidedreportsonprogress made in the planning for the meeting. A major concern was the delay in sending formal invitations to African ministers, such letter should clearly state who is paying for what and should be copied to the relevant mission/embassy in Nairobi. The possibility of including a ministerial side-meeting in the agenda is to be considered, particularly if a large number of ministerial officials are in attendance. The LOC affirmed their expectation of the President of Kenya and the Prime Minister (or at least representatives) to formally open and close the 3rd stakeholders meeting respectively.


10. Staffing: The Task Force agreed that it is important recruit interim personnel especially the Executive Director, who will in turn agree immediate staffing needs such as Resource Mobilization, Advocacy and Administrative support to support the establishment of ANDI in Africa. This would be subject to available funds and UNECA processes.

IV. Action points

Task Responsible person(s)

Deadline

WHO, UNECA to finalize partnership agreement (ANDI work plan and budget to be provided by TDR)

TDR/UNECA 15/09/2010

Resource mobilization strategy (working group to be tasked with developing document ahead of October)


Inclusion of WHO/TDR, EU and UNECA logo›s on conference materials

LOC Immediately

Revised LOC budget to be sent to TDR LOC 10/09/2010

Provide logo›s to UNON for badge design TDR 10/09/2010

Transportation and catering focal points to liaise with UNON TDR/LOC 24/09/2010

Stakeholders meeting agenda to be revised following TF input TDR 10/09/2010

Addendum to SBP to be drafted TDR/UNECA 1/10/2010

Finalize call for R&D projects and share with TF TDR 1/10/2010


LOC and TDR to proceed with planning for the meeting as agreed (particularly for fund-raising, invitations, and facilitating visa on arrival processes).

LOC/TDR Immediately

Immediate staffing needs for ANDI to be addressed following MoU finalization.



Date Activity

Proposed dates:Week of 13th September Teleconference

10 October Pre-Stakeholders meeting (board, STAC).

11 - 13 October 3rd ANDI stakeholders Meeting, UN Offices, Nairobi, Kenya


Annex D1: List of participants

Task Force •TomMboyaOkeyo(Chair),PermanentMissionofKenya,Geneva*•TshinkoIlunga(Vice-Chair),formerlyofAfricanDevelopmentBank,Tunisia•PeterAtadja,Novartis,USA;representingAfricanscientistsintheDiaspora•SanaaBotros,TheodorBilharzResearchInstitute,Egypt•UfordInyang,NationalInstituteforPharmaceuticalResearch&Development,Nigeria•AnastasiaGuantai,UniversityofNairobi,Kenya•AlbrechtJahn,EuropeanCommission,Belgium•AidaOpoku-Mensah,UNECA,Ethiopia•VictorKonde,UNECA,Ethiopia•RobertRidley,TDR•SolomonNwaka,TDR

WHO Secretariat

•RobertRidley,TDR•SolomonNwaka,TDR•FolukeFakorede,TDR•AlexOchem,TDR•MohammadAfzal,EMRO

Others •PatienceKuruneri,AfricanDevelopmentBank,Tunisia•TFOkujagu,MinistryofScience&Technology,Nigeria•JeanSakandé,MinistryofHealth,BurkinaFaso•DanielMotlhanka,BotswanaCollegeofAgriculture,Botswana•SolomonMpoke,KEMRI,Kenya**•JenniferOrwa,KEMRI,Kenya** Joseph Kamotho, Ministry of Public Health and Sanitation, Kenya•CristinaSchulz-Langendorf,UNON,Kenya+


Task Force Kevin McCarthy, European Commission, BelgiumAnthony Mbewu, Global Forum for Health Research, Switzerland

*Participation on day 1; **participation for part of day 1; +participation for part of day 2


Annex D2: Meeting Agenda

Thursday 26 August 2010


Welcome remarks

Dr Tom MBOYA OKEYO Chair, ANDI Task ForceWHO Representative, KenyaDr Rob RIDLEY, Director TDRDr Tshinko ILUNGA (Co-Chair ANDI TF) Ms Aida OPOKU-MENSAH, Director S&T, UNECAChair, LOC 3rd ANDI stakeholders meeting

09:45 - 10:30 Update since last meeting & meeting objectives


10:30 - 10:50 Coffee

10:50 - 12:45 Strategic discussions

Legal hosting and governance•StatusofMoUonlegalhostingofANDI(UNCA/AfDB/WHO)•StatusofestablishmentofANDIaccountandfund•StatusofconstitutionoftheANDIBoard•1st Board meeting (before or after October meeting) - documentation for the Board meeting including all draft strategy documents•OutstandingissuesandhowtoresolvebeforeOctobermeeting

Call for physical hosting of ANDI hubs in Africa and call for applications•LaunchofcallforANDIhubs•ReportontheANDICallforCentresofExcellence•ReviewoflastdraftforcallforprojectstobelaunchedinOctober

12:45 - 14:00 Lunch


15:40 - 16:00 Coffee

16:00 - 16:45 Visit of meeting facilities at UNON

16:45 17:30 Discussion and summary of Day 1


Friday 27 August 2010

09:00 - 10:40 Review of planning for 3rd ANDI meeting (Nairobi)•ReportfromlocalorganizingcommitteeandUNON•Finalmeetingagenda•Registration•Meetingformatanddocumentation•Expectedmeetingoutcomes-launchBoard/STAC, Centres of Excellence•Budget•Outstandingissues

10:40 - 11:00 Coffee

11:00 - 12.30 3rd Stakeholder meeting discussion continues

12:30 - 14:00 Lunch

14:00 - 15:15 Status of other activities/consultations:•Pharmaceuticalmanufacturersmeeting•Francophoneconsultation•Traditionalmedicinesconsultation•Diasporaengagement

15:15 - 15:30 Meeting summary/AOBs Close of meeting

Annex D3: Proposed board and STAC members

Board:- East Africa rep- Southern Africa rep- North Africa rep- West Africa rep- Central Africa rep- European Union - Another representative from non-African agency- An eminent African scientist, R&D or health expert- An eminent African from the diaspora (of African descent)- An eminent African with international recognition - UNECA rep - WHO rep - ADB rep


STAC:

Proposed interim-STAC members and expertise (others to be identified) •SanaaBotros(pharmacologists)•AnastasiaGuantai(Pharmacologist)•PeterAtadja(DrugR&D)•UfordInyang(Regulatoryaffairs)•GlaudinaLoots(Healthinnovation)•AnthonyMbewu(R&Dstrategy)

Required expertise • Basicresearch• Technology/medicaldevices• Productdiscovery(drugs,vaccines,

diagnostics etc)• Pre-clinicaldevelopment• Productdevelopment• Productevaluation• Traditionalmedicines/Naturalproducts• Clinicaltrials• Healthsystems• IP• Ethics/regulatoryissues• Delivery• Epidemiology• Manufacturingandcommercialization

presented at the: 3rd stakeholders meeting & high level ... · 3rd stakeholders meeting &...

Documents